Biotech Growth N V - Jul 18, 2022 Form 4 Insider Report for ESSA Pharma Inc. (EPIX)

Role
10%+ Owner
Signature
/s/ Martin Gubler
Stock symbol
EPIX
Transactions as of
Jul 18, 2022
Transactions value $
$946,740
Form type
4
Date filed
7/20/2022, 03:21 PM
Previous filing
Jul 18, 2022
Next filing
Oct 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EPIX Common Shares Purchase $947K +300K +5.38% $3.16 5.88M Jul 18, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of ESSA Pharma Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.